Talis Biomedical Announces Appointment of Brian Blaser as President, Chief Executive Officer and Director
November 15, 2021 16:02 ET
|
Talis Biomedical Corporation
Veteran executive previously led Abbott's global diagnostics organization Kim Popovits, interim chief executive officer, to resume role as Director on the Board of Talis MENLO PARK, Calif., Nov. ...
Talis Biomedical Granted FDA Emergency Use Authorization (EUA) for COVID-19 Molecular Point-of-Care Test to Detect SARS-CoV-2
November 08, 2021 08:00 ET
|
Talis Biomedical Corporation
Authorized for use in a variety of healthcare and congregate settings, Talis One™ enables lab-quality results without the wait to detect or rule out COVID-19 in less than 30 minutes Talis One’s...
Talis Biomedical to Announce Third Quarter 2021 Financial Results on November 15, 2021
October 26, 2021 08:00 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the...
Talis Biomedical Announces CEO Transition
August 30, 2021 16:30 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at...
Talis Biomedical Announces Second Quarter 2021 Financial Results and Business Progress
August 10, 2021 16:05 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at...
Talis Biomedical to Announce Second Quarter 2021 Financial Results on August 10, 2021
July 27, 2021 08:00 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the...
Talis Biomedical Announces First Quarter 2021 Financial Results and Business Progress
May 11, 2021 16:05 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at...
Talis Biomedical to Announce First Quarter 2021 Financial Results on May 11, 2021
May 04, 2021 08:00 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the...
Talis Biomedical to Participate in Upcoming BofA Securities 2021 Virtual Healthcare Conference
April 28, 2021 08:00 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (“TLIS”), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the...
Talis Appoints Jeryl Hilleman to Board of Directors
March 18, 2021 08:00 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at...